In 2021, the value of quasi-drugs produced in Japan reached close to 1.4 trillion Japanese yen, representing a slight decrease from just over 1.4 billion yen in the previous year. Compared to 2012, the production value of quasi-drugs increased by about 590 billion yen.
Production value of quasi-drugs in Japan from 2012 to 2021 (in billion Japanese yen)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$69 USD $49 USD / Month *
in the first 12 months
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you
Overview
5
- Premium Statistic Pharmaceutical market: worldwide revenue 2001-2022
- Premium Statistic Pharmaceuticals market size South Korea 2008-2021
- Basic Statistic Pharmaceutical spending as share of GDP South Korea 2008-2021
- Basic Statistic Pharmaceutical spending per capita in South Korea 2000-2021
- Premium Statistic Number of pharmaceutical manufacturers South Korea 2008-2021
Production and distribution
6
- Basic Statistic Pharmaceutical production value South Korea 2010-2021
- Premium Statistic OTC drug products production value South Korea 2010-2021
- Premium Statistic Prescription drug products production value South Korea 2010-2021
- Premium Statistic Leading pharmaceutical products South Korea 2021, by production value
- Premium Statistic Number of pharmaceutical distributors South Korea 2010-2021
- Premium Statistic Number of pharmaceutical distributors South Korea 2021, by type
International trade
6
- Premium Statistic Pharmaceutical export value from South Korea 2012-2021
- Premium Statistic Leading countries for pharmaceutical exports South Korea 2021, by export value
- Premium Statistic Biopharmaceuticals export value from South Korea 2012-2021
- Premium Statistic Pharmaceutical import value in South Korea 2012-2021
- Premium Statistic Leading countries for pharmaceutical imports South Korea 2021, by import value
- Premium Statistic Biopharmaceutical import value in South Korea 2012-2021
Key players
6
- Premium Statistic Leading pharmaceutical businesses South Korea 2022, by revenue
- Premium Statistic Yuhan's sales revenue 2015-2021
- Premium Statistic Revenue of GC Pharma 2015-2021
- Premium Statistic Revenue of Chong Kun Dang 2015-2021
- Premium Statistic Annual sales revenue of Kwang Dong Pharmaceutical 2011-2021
- Premium Statistic Hanmi Pharmaceutical sales revenue 2017-2021
OTC pharmaceuticals
6
- Premium Statistic Types of pharmaceutical drugs produced in South Korea 2021, by production value
- Premium Statistic Annual production value of OTC drugs in South Korea 2011-2021
- Premium Statistic Leading generic drugs South Korea 2019, by production value
- Premium Statistic Annual import value of OTC drugs in South Korea 2011-2021
- Premium Statistic Types of pharmaceutical drugs imported into South Korea 2021, by import value share
- Premium Statistic Amount of medication supplied to medical facilities South Korea 2021, by supply value
Further related statistics
18
- Quasi drugs production value in Japan 2021, by therapeutic category
- Breakdown of quasi-drugs production in Japan 2021, by therapeutic category
- Medicated cosmetics production value in Japan 2016, by items
- Medicated cosmetics production quantity in Japan 2016, by item
- Breakdown of quasi-drugs production in Japan 2016, by region
- Quasi-drugs production plants in Japan 2016, by region
- Quasi-drug import value in South Korea 2012-2021
- Quasi-drug market size in South Korea 2012-2021
- Spain: pharmaceutical products imports value 2019
- Hungary: pharmaceutical products imports value 2021
- Poland: pharmaceutical products imports value 2021
- Number of quasi-drugs approved by PMDA Japan FY 2012-2020
- Operating revenue of the sanitary and medical product market in China 2013-2019
- Manufacturing costs in pharmaceutical industry by country 2016
- U.S. pharmaceutical preparations ad spend 2020-2021
- U.S. pharmaceutical preparations: ad spend to sales ratio 2011-2015
- Sales volume of over the counter phytopharmaceuticals and homeopathy in Germany 2018
- Share of the worldwide industrial microbiology market 2014, by sector
Further Content: You might find this interesting as well
Statistics
- Quasi drugs production value in Japan 2021, by therapeutic category
- Breakdown of quasi-drugs production in Japan 2021, by therapeutic category
- Medicated cosmetics production value in Japan 2016, by items
- Medicated cosmetics production quantity in Japan 2016, by item
- Breakdown of quasi-drugs production in Japan 2016, by region
- Quasi-drugs production plants in Japan 2016, by region
- Quasi-drug import value in South Korea 2012-2021
- Quasi-drug market size in South Korea 2012-2021
- Spain: pharmaceutical products imports value 2019
- Hungary: pharmaceutical products imports value 2021
- Poland: pharmaceutical products imports value 2021
- Number of quasi-drugs approved by PMDA Japan FY 2012-2020
- Operating revenue of the sanitary and medical product market in China 2013-2019
- Manufacturing costs in pharmaceutical industry by country 2016
- U.S. pharmaceutical preparations ad spend 2020-2021
- U.S. pharmaceutical preparations: ad spend to sales ratio 2011-2015
- Sales volume of over the counter phytopharmaceuticals and homeopathy in Germany 2018
- Share of the worldwide industrial microbiology market 2014, by sector
MHLW (Japan). (December 23, 2022). Production value of quasi-drugs in Japan from 2012 to 2021 (in billion Japanese yen) [Graph]. In Statista. Retrieved June 08, 2023, from https://www.statista.com/statistics/820996/japan-quasi-drug-production-value/
MHLW (Japan). "Production value of quasi-drugs in Japan from 2012 to 2021 (in billion Japanese yen)." Chart. December 23, 2022. Statista. Accessed June 08, 2023. https://www.statista.com/statistics/820996/japan-quasi-drug-production-value/
MHLW (Japan). (2022). Production value of quasi-drugs in Japan from 2012 to 2021 (in billion Japanese yen). Statista. Statista Inc.. Accessed: June 08, 2023. https://www.statista.com/statistics/820996/japan-quasi-drug-production-value/
MHLW (Japan). "Production Value of Quasi-drugs in Japan from 2012 to 2021 (in Billion Japanese Yen)." Statista, Statista Inc., 23 Dec 2022, https://www.statista.com/statistics/820996/japan-quasi-drug-production-value/
MHLW (Japan), Production value of quasi-drugs in Japan from 2012 to 2021 (in billion Japanese yen) Statista, https://www.statista.com/statistics/820996/japan-quasi-drug-production-value/ (last visited June 08, 2023)
Production value of quasi-drugs in Japan from 2012 to 2021 (in billion Japanese yen) [Graph], MHLW (Japan), December 23, 2022. [Online]. Available: https://www.statista.com/statistics/820996/japan-quasi-drug-production-value/